Major Companies in the Taiwan Acyclovir Market | Competitive Landscape 2026

Major Companies in the Taiwan Acyclovir Market

The Taiwan Acyclovir Market is a strategic blend of global pharma companies and high-capacity domestic manufacturers, competing for the market share, with sophisticated antiviral formulations and strong distribution networks. Key players in the market are GSK Taiwan, Yung Shin Pharmaceutical, and CCPC (China Chemical & Pharmaceutical Co.).

Taiwan Acyclovir Market Overview

According to 6Wresearch, the Taiwan Acyclovir Market is expected to witness a steady growth rate, owing to an increased prevalence of viral infections, such as Herpes Simplex (HSV), Varicella-Zoster (shingles), and chickenpox. Acyclovir is a synthetic nucleoside analogue, and a vital antiviral drug that inhibits viral DNA synthesis. The growth of the market is attributed to the increased availability of antiviral drugs in healthcare facilities in urban and rural areas. The specialized development in the delivery of topical and oral drugs, and the inclusion of Acyclovir in the National Health Insurance (NHI) reimbursement programs, have made these therapies essential for the people of Taiwan.

Competitive Landscape

The Taiwan Acyclovir Industry is highly competitive, with a mix of major multinational pharmaceutical companies and leading local players. The key players have expertise in infectious diseases and dermatology, and are committed to enhancing patient health and well-being by providing access to high quality antiviral agents in a range of formats such as tablets, creams and ophthalmic ointments.

Below is a list of leading players operating in the Taiwan Acyclovir Market:

1. GSK Taiwan (GlaxoSmithKline)

GSK is the innovator behind Zovirax, a global standard for Acyclovir, and maintains a dominant position in the premium antiviral segment in Taiwan.

2. Yung Shin Pharmaceutical Ind. Co., Ltd.

Yung Shin is one of the largest pharmaceutical companies in Taiwan, providing widely accessible and affordable generic Acyclovir formulations.

3. China Chemical & Pharmaceutical Co., Ltd. (CCPC)

CCPC is a leading domestic player that offers high-quality antiviral treatments, focusing on international manufacturing standards and local hospital supply chains.

4. Synmosa Biopharma Corporation

Synmosa focuses on specialized therapeutic segments and provides high-standard antiviral agents, leveraging a diverse portfolio that includes respiratory treatments.

5. Standard Chem. & Pharm. Co., Ltd.

Standard is a major domestic player known for its strong distribution network and diverse portfolio of essential medicines, including systemic antivirals.

6. Lotus Pharmaceutical Co., Ltd.

Lotus is a fast-growing specialty pharmaceutical company that utilizes advanced facilities to supply essential medicines across international markets.

7. Swiss Pharmaceutical Co., Ltd.

Swiss Pharmaceutical specializes in high-quality manufacturing and exports, offering specialized Acyclovir formulations that meet international quality benchmarks.

8. TTY Biopharm Company Limited

TTY Biopharm plays a vital role in manufacturing generic antivirals and oncology treatments, focusing on high-barrier technologies for the local market.

9. Orient EuroPharma Co., Ltd. (OEP)

OEP leverages an extensive retail and distribution network to ensure essential antiviral treatments reach pharmacies and hospitals nationwide.

10. Sintong Information Co., Ltd. (Sintong Pharm)

Sintong focuses on marketing and distributing high-efficacy pharmaceutical products, including topical and oral antiviral agents for the general population.

Major Companies in the Taiwan Acyclovir Market: FAQs